XML 108 R8.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common shares
Common shares
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury shares
Treasury shares
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional paid in capital
Additional paid in capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Other Comprehensive (Loss)/Income
Other Comprehensive (Loss)/Income
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
Non- controlling interest
Non- controlling interest
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2018       52,534,175                        
Beginning balance at Dec. 31, 2018 $ 1,533.5     $ 5.3   $ (26.2)   $ 1,837.5   $ (5.6)   $ (279.2)     $ 1.7  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issue of common shares (in shares)       2,875,000                        
Issue of common shares 53.5     $ 0.3       53.2                
Equity issuance costs (4.3)             (4.3)                
Stock based compensation 3.9             3.9                
Total comprehensive income/(loss) (293.5)                 5.6   (297.6)     (1.5)  
Other, net 1.0             0.9       0.1        
Ending balance (in shares) at Dec. 31, 2019       55,409,175 55,409,175                      
Ending balance at Dec. 31, 2019 $ 1,294.1 $ (2.9) $ 1,291.2 $ 5.6 $ 5.6 (26.2) $ (26.2) 1,891.2 $ 1,891.2 0.0 $ 0.0 (576.7) $ (2.9) $ (579.6) 0.2 $ 0.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13 [Member]                              
Issue of common shares (in shares) 54,020,319     54,020,319                        
Issue of common shares $ 62.8     $ 5.4       57.4                
Equity issuance costs (2.6)             (2.6)                
Stock based compensation 0.7             0.7                
Total comprehensive income/(loss) (317.6)                     (317.6)        
Other, net 2.3             0.5       2.0     (0.2)  
Ending balance (in shares) at Dec. 31, 2020       109,429,494                        
Ending balance at Dec. 31, 2020 1,036.8     $ 11.0   (26.2)   1,947.2   0.0   (895.2)     0.0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issue of common shares (in shares)       27,058,823                        
Issue of common shares 46.0     $ 2.8       43.2                
Equity issuance costs (1.2)             (1.2)                
Stock based compensation (in shares)       323,525                        
Stock based compensation 0.9         12.5   (11.6)                
Total comprehensive income/(loss) (193.0)                     (193.0)        
Other, net 0.4             0.4                
Ending balance (in shares) at Dec. 31, 2021       136,811,842                        
Ending balance at Dec. 31, 2021 $ 889.9     $ 13.8   $ (13.7)   $ 1,978.0   $ 0.0   $ (1,088.2)     $ 0.0